Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Urine
about
Analysis of bacterial biofilms using NMR-based metabolomicsMetabolomics in plants and humans: applications in the prevention and diagnosis of diseasesEpidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesGallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD miceStandardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a reviewCan NMR solve some significant challenges in metabolomics?Rats' urinary metabolomes reveal the potential roles of functional foods and exercise in obesity management.Statistical analysis and modeling of mass spectrometry-based metabolomics data.Identification of Reliable Components in Multivariate Curve Resolution-Alternating Least Squares (MCR-ALS): a Data-Driven Approach across Metabolic Processes.Microextraction by Packed Sorbent (MEPS) and Solid-Phase Microextraction (SPME) as Sample Preparation Procedures for the Metabolomic Profiling of Urine.Diagnostic Applications of Nuclear Magnetic Resonance-Based Urinary Metabolomics(1)H NMR-based metabolic profiling reveals inherent biological variation in yeast and nematode model systems.Catabolite control protein A is an important regulator of metabolism in Streptococcus suis type 2.Bioinformatics Tools for Mass Spectroscopy-Based Metabolomic Data Processing and Analysis.Metabonomic profiling of serum and urine by (1)H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individuals.Plasma metabolite profiling and chemometric analyses of lung cancer along with three controls through gas chromatography-mass spectrometry.Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry.Metabolic shifts induced by human H460 cells in tumor-bearing mice.Accuracy of volatile urine biomarkers for the detection and characterization of lung cancer.Metabolomic investigation of regional brain tissue dysfunctions induced by global cerebral ischemiaThe Intervention Effects of Acupuncture on Fatigue Induced by Exhaustive Physical Exercises: A Metabolomics Investigation.Volatile Organic Metabolites Identify Patients with Mesangial Proliferative Glomerulonephritis, IgA Nephropathy and Normal Controls.Metabolic differentiation and classification of abnormal Savda Munziq's pharmacodynamic role on rat models with different diseases by nuclear magnetic resonance-based metabonomics.1H NMR Metabolomics Reveals Association of High Expression of Inositol 1, 4, 5 Trisphosphate Receptor and Metabolites in Breast Cancer PatientsMetabolic Profiling Comparison of Human Pancreatic Ductal Epithelial Cells and Three Pancreatic Cancer Cell Lines using NMR Based Metabonomics.Cordyceps sinensis protects against liver and heart injuries in a rat model of chronic kidney disease: a metabolomic analysis.Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatmentBiomarker Discovery and Translation in Metabolomics.Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer.High resolution metabolomics to discriminate compounds in serum of male lung cancer patients in South Korea.Distinct metabolic profile of primary focal segmental glomerulosclerosis revealed by NMR-based metabolomics.Glycoproteomics using fluid-based specimens in the discovery of lung cancer protein biomarkers: promise and challenge.Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma.Differentiating hepatocellular carcinoma from hepatitis C using metabolite profiling.The future of NMR metabolomics in cancer therapy: towards personalizing treatment and developing targeted drugs?Metabolic profiling of plasma from benign and malignant pulmonary nodules patients using mass spectrometry-based metabolomics.A characteristic biosignature for discrimination of gastric cancer from healthy population by high throughput GC-MS analysis.Recent advances in metabolomics in oncology.NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis.Metabolic profiling of biofluids: potential in lung cancer screening and diagnosis.
P2860
Q26851303-22F59931-7822-4D96-AADA-2DBC80BC262DQ27016117-B51B94E8-C5AD-448F-84DA-300EC16972EEQ27023830-9B2F05FC-B278-48DB-BE15-B35129D57DC0Q27333713-97BEC3B0-772E-4D85-9767-9E9CFA2B993CQ28083342-60A5A798-0E4F-4851-8E73-114BE129E6E5Q28087461-2053FDFD-C305-483D-B8F4-EC9495CBAEBEQ30313428-81DF5B1C-9AF4-4CA9-A37A-DB6B70EA5742Q30856706-9039D4ED-62CD-4351-AC3E-CB35F7E91CE0Q31016419-1BDC0660-66DB-4612-B1C0-AC62E29657B6Q33601018-49A92116-E39B-4ED6-8BE0-B921E803EB93Q33670799-6A68CF64-2689-4537-83D4-1DF21830D833Q33829694-3A911F33-9AF6-4911-A8E1-7C0DAB5BECA1Q33932021-4A609DF2-B401-4275-AA6A-B7D62A153269Q34205992-752D0569-8149-4900-A52D-1AC1601D1484Q34766684-C34899EC-02B9-4FCD-9535-93DB1EADD2C8Q35119518-080E5164-3BE9-4C14-81C7-2BC858D628E5Q35653903-64DC2A2F-E279-4FEC-A658-E986D577299AQ35683856-83732D35-1BCF-4947-9742-7EAE4164506FQ35876957-8A96DBB8-7550-45B0-9DB9-19FF03655F3BQ36024574-940091E1-B5AB-4578-A2EE-73A9A414AD78Q36084252-BDF2F2E0-D274-47FC-9508-46DA35057DA4Q36129126-2A64863A-D70F-4769-83D8-7DA0B59D7F38Q36209947-D9EB3650-0914-47DE-81C0-C18B026FB6A6Q36245590-0A78880C-229A-4FE1-80B5-937E2A5964C9Q36307024-0870D0EA-0AFB-4495-B511-8C73159FFEC8Q36745803-6C96B4C6-A00E-4D97-965E-B8388BBA80F7Q36761890-CD4D9348-FFBD-4249-8FA5-1203525260FCQ36845593-F1E283A2-B834-47A8-AE9F-0A301E21A01BQ37022332-1DECB2E3-B24D-4F63-B004-BEC20B25C79CQ37160389-5DF09CFC-7E6C-4534-A152-F4DF52BF1058Q37297472-3E3926CC-E2D6-4168-B4FC-FE9FF350CDB8Q37365408-F8931AD0-F987-4802-921F-40812F29A0B3Q37421650-D4E265AD-EEBE-476F-83B7-60850F8CE898Q37512658-62A54929-9A8F-4B10-9AA2-2F69F29FFB18Q37512764-4C674160-56A8-41A6-A98E-8429332C3C26Q37512790-C53B0829-81FB-4BCD-8AC6-77090D803577Q37699460-6FFFAC1C-B69A-450E-BFD2-992EE497B85AQ37990967-F94382E8-2F4B-43C0-B767-DD2F619DA7DAQ38119451-2727C2D8-84B0-45ED-A219-9F533FC6B016Q38142255-0245008B-9C56-4EE4-9B64-0E10232BEEEB
P2860
Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Urine
description
im November 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 23 November 2010
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2011
@uk
name
Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Urine
@en
Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Urine
@nl
type
label
Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Urine
@en
Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Urine
@nl
prefLabel
Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Urine
@en
Metabolic Signatures of Lung Cancer in Biofluids: NMR-Based Metabonomics of Urine
@nl
P2093
P50
P356
P1476
Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine
@en
P2093
João Bernardo
Vitor Sousa
P304
P356
10.1021/PR100899X
P50
P577
2010-11-23T00:00:00Z